tetradecanoylphorbol acetate has been researched along with salvianolic acid B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Cho, S; Hong, B; Si, S; Wang, L; Xu, Y; Yang, Y | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and salvianolic acid B
| Article | Year |
|---|---|
Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzofurans; Biological Transport; CD36 Antigens; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; RNA Interference; Surface Plasmon Resonance; Tetradecanoylphorbol Acetate; Time Factors; Transfection | 2012 |